Development of a new in vitro test for drugs and vaccine design against plus-stranded rna viruses containig ires elements

Informations projet

GIOVANNA BERGAMINI

N° de convention de subvention: QLK2-CT-1999-51489

Projet clôturé

Date de début 1 Avril 2000

Date de fin 30 Septembre 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 112 800,00

Contribution de l’UE € 112 800,00

Coordonné par

EUROPEAN MOLECULAR BIOLOGY LABORATORY
Germany

Objectif

The goal of this work is to optimise an in vitro system:
i) for testing anti-viral compounds that exclusively reduce translation from viral IRES containing mRNAs and;
ii) for rational design of mutations reducing efficiency of viral translation for the development of attenuated vaccine.

Champ scientifique

• medical and health sciences › health sciences › infectious diseases › RNA viruses
• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• natural sciences › biological sciences › genetics › mutation
• natural sciences › biological sciences › genetics › RNA

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

EUROPEAN MOLECULAR BIOLOGY LABORATORY

• Contribution de l’UE: Aucune donnée
• Adresse: Meyerhofstrasse 1 ; HEIDELBERG ; Allemagne
• Coût total: Aucune donnée